-
Je něco špatně v tomto záznamu ?
Wnt-expressing rat embryonic fibroblasts suppress Apo2L/TRAIL-induced apoptosis of human leukemia cells
L Doubravska, S Simova, L Cermak, T Valenta, V Korinek, L Andera
Jazyk angličtina Země Spojené státy americké
NLK
ProQuest Central
od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2000-02-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01 do Před 1 rokem
- MeSH
- apoptóza fyziologie MeSH
- beta-katenin fyziologie MeSH
- cykloheximid farmakologie MeSH
- daktinomycin farmakologie MeSH
- financování organizované MeSH
- kokultivační techniky MeSH
- krysa rodu rattus MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- pre-B-buněčná leukemie MeSH
- protein TRAIL antagonisté a inhibitory MeSH
- protein Wnt1 biosyntéza MeSH
- proteiny regulující apoptózu fyziologie MeSH
- proteiny Wnt biosyntéza MeSH
- signální transdukce fyziologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- lidé MeSH
- zvířata MeSH
Wnt signaling enhances cell proliferation and the maintenance of hematopoietic cells. In contrast, cytotoxic ligand Apo2L/TRAIL induces the apoptosis of various transformed cells. We observed that co-culture of human pre-B leukemia cells KM3 and REH with Wnt1- or Wnt3a-producing rat embryonic fibroblasts efficiently suppressed Apo2L/TRAIL-induced apoptosis of the lymphoid cells. This suppression occurs at the early stages of the Apo2L/TRAIL apoptotic cascade and, interestingly, the activation of the Wnt pathway alone in human leukemia cells is not sufficient for their full anti-apoptotic protection. We hypothesize that a stimulus emanating specifically from Wnt1- or Wnt3a-expressing rat fibroblasts is responsible for the observed resistance to Apo2L/TRAIL. This anti-apoptotic signaling was significantly hampered by the inhibition of the MEK1/ERK1/2 or NFkappaB pathways in KM3 and REH cells. Our results imply that paracrine Wnt-related signals could be important for the survival of pre-B cell-derived malignancies.
- 000
- 02785naa 2200445 a 4500
- 001
- bmc11003657
- 003
- CZ-PrNML
- 005
- 20121101121555.0
- 008
- 110302s2008 xxu e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Doubravská, Lenka $7 xx0127829
- 245 10
- $a Wnt-expressing rat embryonic fibroblasts suppress Apo2L/TRAIL-induced apoptosis of human leukemia cells / $c L Doubravska, S Simova, L Cermak, T Valenta, V Korinek, L Andera
- 314 __
- $a Laboratory of Cell and Developmental Biology, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Videnska 1083, 14220, Praha 4, Czech Republic.
- 520 9_
- $a Wnt signaling enhances cell proliferation and the maintenance of hematopoietic cells. In contrast, cytotoxic ligand Apo2L/TRAIL induces the apoptosis of various transformed cells. We observed that co-culture of human pre-B leukemia cells KM3 and REH with Wnt1- or Wnt3a-producing rat embryonic fibroblasts efficiently suppressed Apo2L/TRAIL-induced apoptosis of the lymphoid cells. This suppression occurs at the early stages of the Apo2L/TRAIL apoptotic cascade and, interestingly, the activation of the Wnt pathway alone in human leukemia cells is not sufficient for their full anti-apoptotic protection. We hypothesize that a stimulus emanating specifically from Wnt1- or Wnt3a-expressing rat fibroblasts is responsible for the observed resistance to Apo2L/TRAIL. This anti-apoptotic signaling was significantly hampered by the inhibition of the MEK1/ERK1/2 or NFkappaB pathways in KM3 and REH cells. Our results imply that paracrine Wnt-related signals could be important for the survival of pre-B cell-derived malignancies.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a apoptóza $x fyziologie $7 D017209
- 650 _2
- $a proteiny regulující apoptózu $x fyziologie $7 D051017
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a kokultivační techniky $7 D018920
- 650 _2
- $a cykloheximid $x farmakologie $7 D003513
- 650 _2
- $a daktinomycin $x farmakologie $7 D003609
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a pre-B-buněčná leukemie $7 D015452
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a signální transdukce $x fyziologie $7 D015398
- 650 _2
- $a protein TRAIL $x antagonisté a inhibitory $7 D053221
- 650 _2
- $a proteiny Wnt $x biosyntéza $7 D051153
- 650 _2
- $a protein Wnt1 $x biosyntéza $7 D051155
- 650 _2
- $a beta-katenin $x fyziologie $7 D051176
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Šímová, Šárka. $7 xx0222884
- 700 1_
- $a Čermák, Lukáš $7 xx0140314
- 700 1_
- $a Valenta, Tomáš. $7 _AN031325
- 700 1_
- $a Kořínek, Vladimír, $d 1963- $7 xx0128610
- 700 1_
- $a Anděra, Ladislav $7 xx0140308
- 773 0_
- $t Apoptosis $w MED00007546 $g Roč. 13, č. 4 (2008), s. 573-587
- 910 __
- $a ABA008 $b x $y 7
- 990 __
- $a 20110413105119 $b ABA008
- 991 __
- $a 20121101121559 $b ABA008
- 999 __
- $a ok $b bmc $g 831070 $s 695678
- BAS __
- $a 3
- BMC __
- $a 2008 $b 13 $c 4 $d 573-587 $m Apoptosis $n Apoptosis $x MED00007546
- LZP __
- $a 2011-3B/vtme